Skip to content

Clinical trials

Phase 2 Small Cell Lung Carcinoma trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Phase: Phase 2 Country / region: Spain Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20072
20101
20121
20143
20152
20161
20171
20201
20217
20222
20232
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated7
Recruiting6
Active, not recruiting5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
Amgen2
Pfizer2
AbbVie1
Advenchen Pharmaceuticals, LLC.1
AstraZeneca1
Boehringer Ingelheim1
Bristol-Myers Squibb1
Celgene1
Clinica Universidad de Navarra, Universidad de Navarra1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma29
Carcinoma, Non-Small-Cell Lung4
Anus Neoplasms2
Carcinoma, Renal Cell2
Carcinoma, Small Cell2
Lung Neoplasms2
Melanoma2
Squamous Cell Carcinoma of Head and Neck2
Adenocarcinoma of Lung1
Carcinoma, Hepatocellular1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.